Ys Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ys biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ys Biopharma Today - Breaking & Trending Today

YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript

YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript April 19, 2024 YS Biopharma Co., Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by and welcome to YS Biopharma’s Earnings Call […] ....

Brenda Wu , Zenaida Mojares , Chief Financial Officer , Ys Biopharma , Rabies Vaccine , Ys Biopharma Co , 024 Ys Biopharma Co , Product Sales , Zenaida Mojares , David Shao ,

YS Biopharma (NASDAQ:YS) Trading Down 3.4%

YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) shares were down 3.4% during mid-day trading on Friday . The company traded as low as $0.39 and last traded at $0.40. Approximately 99,903 shares were traded during trading, a decline of 41% from the average daily volume of 168,291 shares. The stock had previously closed […] ....

Topco Ltd , Barclays Plc , Ys Biopharma Company Profile , Ys Biopharma Co Ltd , Prelude Capital Management , Get Free Report , Noble Financial , Capital Management , Ys Biopharma , Nasdaq Ys ,

Noble Financial Begins Coverage on YS Biopharma (NASDAQ:YS)

Noble Financial assumed coverage on shares of YS Biopharma (NASDAQ:YS – Free Report) in a research report released on Monday morning, Benzinga reports. The brokerage issued an outperform rating and a $5.25 price target on the stock. YS Biopharma Stock Down 1.4 % NASDAQ YS opened at $0.65 on Monday. The company has a current […] ....

Topco Ltd , Ys Biopharma Company Profile , Barclays Plc , Prelude Capital Management , Hhlr Advisors , Ys Biopharma Co Ltd , Noble Financial , Free Report , Stock Down , Get Free Report , Capital Management , Ys Biopharma , Nasdaq Ys , Initiated Coverage ,

YS Biopharma Co., Ltd. (NASDAQ:YS) Short Interest Down 86.1% in September

YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 98,300 shares, a drop of 86.1% from the August 31st total of 706,300 shares. Based on an average trading volume of 922,700 shares, the days-to-cover […] ....

Topco Ltd , Barclays Plc , Ys Biopharma Co Ltd , Hhlr Advisors , Prelude Capital Management , Get Free Report , Ys Biopharma , Nasdaq Ys ,